560 related articles for article (PubMed ID: 34535131)
1. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
2. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
3. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
[TBL] [Abstract][Full Text] [Related]
4. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19.
Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL
Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Dehghan Z; Mirmotalebisohi SA; Mozafar M; Sameni M; Saberi F; Derakhshanfar A; Moaedi J; Zohrevand H; Zali H
Daru; 2024 Jun; 32(1):215-235. PubMed ID: 38652363
[TBL] [Abstract][Full Text] [Related]
7. Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics.
Chakrabarty B; Das D; Bulusu G; Roy A
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1271-1280. PubMed ID: 33891554
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
9. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
10. Topological network based drug repurposing for coronavirus 2019.
Habibi M; Taheri G
PLoS One; 2021; 16(7):e0255270. PubMed ID: 34324563
[TBL] [Abstract][Full Text] [Related]
11. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
Mousavi SZ; Rahmanian M; Sami A
Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005
[TBL] [Abstract][Full Text] [Related]
12. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
Sadegh S; Matschinske J; Blumenthal DB; Galindez G; Kacprowski T; List M; Nasirigerdeh R; Oubounyt M; Pichlmair A; Rose TD; Salgado-Albarrán M; Späth J; Stukalov A; Wenke NK; Yuan K; Pauling JK; Baumbach J
Nat Commun; 2020 Jul; 11(1):3518. PubMed ID: 32665542
[TBL] [Abstract][Full Text] [Related]
13. A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing.
Habibi M; Taheri G; Aghdam R
Sci Rep; 2021 Apr; 11(1):9378. PubMed ID: 33931664
[TBL] [Abstract][Full Text] [Related]
14. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
15. Network analytics for drug repurposing in COVID-19.
Siminea N; Popescu V; Sanchez Martin JA; Florea D; Gavril G; Gheorghe AM; Iţcuş C; Kanhaiya K; Pacioglu O; Popa LL; Trandafir R; Tusa MI; Sidoroff M; Păun M; Czeizler E; Păun A; Petre I
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864885
[TBL] [Abstract][Full Text] [Related]
16. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
Belyaeva A; Cammarata L; Radhakrishnan A; Squires C; Yang KD; Shivashankar GV; Uhler C
Nat Commun; 2021 Feb; 12(1):1024. PubMed ID: 33589624
[TBL] [Abstract][Full Text] [Related]
17. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients.
Wang H; Zhang J; Lu Z; Dai W; Ma C; Xiang Y; Zhang Y
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34505138
[TBL] [Abstract][Full Text] [Related]
19. A network biology approach to identify crucial host targets for COVID-19.
Barman RK; Mukhopadhyay A; Maulik U; Das S
Methods; 2022 Jul; 203():108-115. PubMed ID: 35364279
[TBL] [Abstract][Full Text] [Related]
20. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
Ackerman EE; Shoemaker JE
Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
